INCY - Company ID 0000879169
The table below shows INCYTE CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B |
| Cost of revenue | $372.13M | $312.07M | $254.99M | $207.00M | $150.99M | $131.33M |
| Gross profit | - | - | - | - | - | - |
| R&D | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B |
| SG&A |
INCYTE CORP reported annual revenue of $5.14B for fiscal year 2025. That is up 21.2% from $4.24B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.11B (FY 2016) to $5.14B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.38B |
| $1.24B |
| $1.16B |
| $1.00B |
| $739.56M |
| $516.92M |
| Operating income | $1.51B | $61.37M | $620.52M | $579.44M | $585.78M | -$263.68M |
| Income tax | $377.80M | $284.01M | $236.62M | $188.46M | -$378.14M | $63.48M |
| Net income | $1.29B | $32.60M | $597.60M | $340.70M | $948.60M | -$295.70M |
| EPS (diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | -$1.36 |